Impact	Impact	NN	B-NP	O	
of	of	IN	B-PP	O	
intracranial	intracranial	JJ	B-NP	O	
pressure	pressure	NN	I-NP	O	
monitor	monitor	NN	I-NP	O	
prophylaxis	prophylaxis	NN	I-NP	O	
on	on	IN	B-PP	O	
central	central	JJ	B-NP	O	
nervous	nervous	JJ	I-NP	O	
system	system	NN	I-NP	O	
infections	infection	NNS	I-NP	O	
and	and	CC	O	O	
bacterial	bacterial	JJ	B-NP	O	
multi	multi	AFX	I-NP	O	
-	-	HYPH	I-NP	O	
drug	drug	NN	I-NP	O	
resistance	resistance	NN	I-NP	O	
.	.	.	O	O	

Routine	Routine	NN	B-NP	O	
intracranial	intracranial	JJ	I-NP	O	
pressure	pressure	NN	I-NP	O	
monitor	monitor	NN	I-NP	O	
(	(	(	O	O	
ICP	ICP	NN	B-NP	O	
)	)	)	O	O	
prophylaxis	prophylaxis	NN	B-NP	O	
is	be	VBZ	B-VP	O	
not	not	RB	I-VP	O	
practiced	practice	VBN	I-VP	O	
at	at	IN	B-PP	O	
our	our	PRP$	B-NP	O	
institution	institution	NN	I-NP	O	
.	.	.	O	O	

Nevertheless	Nevertheless	RB	B-ADVP	O	
,	,	,	O	O	
some	some	DT	B-NP	O	
patients	patient	NNS	I-NP	O	
receive	receive	VBP	B-VP	O	
de facto	de_facto	NN	B-NP	O	
prophylaxis	prophylaxis	NN	I-NP	O	
as	as	IN	B-PP	O	
a	a	DT	B-NP	O	
result	result	NN	I-NP	O	
of	of	IN	B-PP	O	
the	the	DT	B-NP	O	
use	use	NN	I-NP	O	
of	of	IN	B-PP	O	
antibiotics	antibiotic	NNS	B-NP	O	
for	for	IN	B-PP	O	
injuries	injury	NNS	B-NP	O	
such	such	JJ	B-PP	O	
as	as	IN	I-PP	O	
open	open	JJ	B-NP	O	
or	or	CC	I-NP	O	
facial	facial	JJ	I-NP	O	
fractures	fracture	NNS	I-NP	O	
.	.	.	O	O	

We	We	PRP	B-NP	O	
tested	test	VBD	B-VP	O	
the	the	DT	B-NP	O	
hypothesis	hypothesis	NN	I-NP	O	
that	that	IN	B-SBAR	O	
prophylactic	prophylactic	JJ	B-NP	O	
antibiotics	antibiotic	NNS	I-NP	O	
do	do	VBP	B-VP	O	
not	not	RB	I-VP	O	
reduce	reduce	VB	I-VP	O	
the	the	DT	B-NP	O	
incidence	incidence	NN	I-NP	O	
of	of	IN	B-PP	O	
central	central	JJ	B-NP	O	
nervous	nervous	JJ	I-NP	O	
system	system	NN	I-NP	O	
(	(	(	O	O	
CNS	CNS	NN	B-NP	B-protein	
)	)	)	O	O	
infections	infection	NNS	B-NP	O	
but	but	CC	O	O	
instead	instead	RB	B-VP	O	
are	be	VBP	I-VP	O	
associated	associate	VBN	I-VP	O	
with	with	IN	B-PP	O	
the	the	DT	B-NP	O	
acquisition	acquisition	NN	I-NP	O	
of	of	IN	B-PP	O	
multi	multi	AFX	B-NP	O	
-	-	HYPH	I-NP	O	
drug	drug	NN	I-NP	O	
resistant	resistant	JJ	I-NP	O	
(	(	(	O	O	
MDR	MDR	NN	B-NP	B-protein	
)	)	)	O	O	
bacterial	bacterial	JJ	B-NP	O	
infections	infection	NNS	I-NP	O	
.	.	.	O	O	

Patients	Patient	NNS	B-NP	O	
admitted	admit	VBN	B-VP	O	
to	to	TO	B-PP	O	
the	the	DT	B-NP	O	
trauma	trauma	NN	I-NP	B-DNA	
intensive	intensive	JJ	I-NP	I-DNA	
care	care	NN	I-NP	I-DNA	
unit	unit	NN	I-NP	I-DNA	
(	(	(	O	O	
TICU	TICU	NN	B-NP	B-DNA	
)	)	)	O	O	
from	from	IN	B-PP	O	
January	January	NNP	B-NP	O	
,	,	,	O	O	
2001	2001	CD	B-NP	O	
through	through	IN	B-PP	O	
December	December	NNP	B-NP	O	
,	,	,	O	O	
2004	2004	CD	B-NP	O	
with	with	IN	B-PP	O	
blunt	blunt	NN	B-NP	O	
,	,	,	O	O	
non-operative	non-operative	JJ	B-NP	O	
traumatic	traumatic	JJ	I-NP	O	
brain	brain	NN	I-NP	O	
injury	injury	NN	I-NP	O	
who	who	WP	B-NP	O	
were	be	VBD	B-VP	O	
managed	manage	VBN	I-VP	O	
solely	solely	RB	B-ADVP	O	
with	with	IN	B-PP	O	
an	an	DT	B-NP	O	
ICP	ICP	NN	I-NP	O	
monitor	monitor	NN	I-NP	O	
were	be	VBD	B-VP	O	
identified	identify	VBN	I-VP	O	
from	from	IN	B-PP	O	
our	our	PRP$	B-NP	O	
trauma	trauma	NN	I-NP	O	
registry	registry	NN	I-NP	O	
and	and	CC	O	O	
divided	divide	VBN	B-VP	O	
into	into	IN	B-PP	O	
two	two	CD	B-NP	O	
groups	group	NNS	I-NP	O	
:	:	:	O	O	
(	(	(	B-LST	O	
1	1	LS	I-LST	O	
)	)	)	O	O	
Those	Those	DT	O	O	
receiving	receive	VBG	B-VP	O	
no	no	DT	B-NP	O	
antibiotics	antibiotic	NNS	I-NP	O	
prior	prior	JJ	B-ADJP	O	
to	to	TO	B-PP	O	
or	or	CC	O	O	
during	during	IN	B-PP	O	
ICP	ICP	NN	B-NP	O	
monitoring	monitoring	NN	I-NP	O	
(	(	(	O	O	
NONE	NONE	NN	B-NP	O	
;	;	:	O	O	
n	n	NN	B-NP	O	
=	=	SYM	B-VP	O	
71	71	CD	B-NP	O	
)	)	)	O	O	
;	;	:	O	O	
and	and	CC	O	O	
(	(	(	B-LST	O	
2	2	LS	I-LST	O	
)	)	)	O	O	
those	those	DT	B-NP	O	
already	already	RB	B-ADVP	O	
receiving	receive	VBG	B-VP	O	
antibiotics	antibiotic	NNS	B-NP	O	
at	at	IN	B-PP	O	
the	the	DT	B-NP	O	
time	time	NN	I-NP	O	
of	of	IN	B-PP	O	
ICP	ICP	NN	B-NP	O	
monitor	monitor	NN	I-NP	O	
insertion	insertion	NN	I-NP	O	
(	(	(	O	O	
PRO	PRO	NN	B-NP	O	
;	;	:	O	O	
n	n	NN	B-NP	O	
=	=	SYM	B-VP	O	
84	84	CD	B-NP	O	
)	)	)	O	O	
.	.	.	O	O	

Groups	Group	NNS	B-NP	O	
were	be	VBD	B-VP	O	
stratified	stratify	VBN	I-VP	O	
on	on	IN	B-PP	O	
the	the	DT	B-NP	O	
basis	basis	NN	I-NP	O	
of	of	IN	B-PP	O	
age	age	NN	B-NP	O	
,	,	,	O	O	
Injury	Injury	NN	B-NP	O	
Severity	Severity	NN	I-NP	O	
Score	Score	NN	I-NP	O	
(	(	(	O	O	
ISS	ISS	NN	B-NP	B-protein	
)	)	)	O	O	
,	,	,	O	O	
Glasgow	Glasgow	NNP	B-NP	O	
Coma	Coma	NNP	I-NP	O	
Scale	Scale	NNP	I-NP	O	
(	(	(	O	O	
GCS	GCS	NN	B-NP	O	
)	)	)	O	O	
Score	Score	NN	B-NP	O	
,	,	,	O	O	
base	base	NN	B-NP	O	
excess	excess	NN	I-NP	O	
(	(	(	O	O	
BE	BE	NN	B-NP	O	
)	)	)	O	O	
,	,	,	O	O	
ICP	ICP	NN	B-NP	O	
days	day	NNS	I-NP	O	
,	,	,	O	O	
transfusions	transfusion	NNS	B-NP	O	
in	in	IN	B-PP	O	
24	24	CD	B-NP	O	
h	h	NN	I-NP	O	
,	,	,	O	O	
ICU	ICU	NN	B-NP	O	
days	day	NNS	I-NP	O	
,	,	,	O	O	
ventilator	ventilator	NN	B-NP	O	
days	day	NNS	I-NP	O	
,	,	,	O	O	
head	head	NN	B-NP	O	
Abbreviated	Abbreviate	VBD	B-VP	O	
Injury	Injury	NN	B-NP	O	
Score	Score	NN	I-NP	O	
(	(	(	O	O	
AIS	AIS	NN	B-NP	O	
)	)	)	O	O	
,	,	,	O	O	
and	and	CC	O	O	
chest	chest	NN	B-NP	O	
AIS	AIS	NN	I-NP	O	
.	.	.	O	O	

The	The	DT	B-NP	O	
study	study	NN	I-NP	O	
groups	group	NNS	I-NP	O	
did	do	VBD	B-VP	O	
not	not	RB	I-VP	O	
differ	differ	VB	I-VP	O	
with	with	IN	B-PP	O	
respect	respect	NN	B-NP	O	
to	to	TO	B-PP	O	
age	age	NN	B-NP	O	
,	,	,	O	O	
ISS	ISS	NN	B-NP	B-protein	
,	,	,	O	O	
GCS	GCS	NN	B-NP	O	
,	,	,	O	O	
BE	BE	NN	B-NP	O	
,	,	,	O	O	
ICP	ICP	NN	B-NP	O	
days	day	NNS	I-NP	O	
,	,	,	O	O	
24-h	24-h	JJ	B-NP	O	
transfusions	transfusion	NNS	I-NP	O	
,	,	,	O	O	
ICU	ICU	NN	B-NP	O	
days	day	NNS	I-NP	O	
,	,	,	O	O	
ventilator	ventilator	NN	B-NP	O	
days	day	NNS	I-NP	O	
,	,	,	O	O	
head	head	NN	B-NP	O	
AIS	AIS	NN	I-NP	O	
,	,	,	O	O	
or	or	CC	O	O	
length	length	NN	B-NP	O	
of	of	IN	B-PP	O	
stay	stay	NN	B-NP	O	
.	.	.	O	O	

In	In	IN	B-PP	O	
all	all	DT	B-NP	O	
,	,	,	O	O	
183	183	CD	B-NP	O	
patients	patient	NNS	I-NP	O	
were	be	VBD	B-VP	O	
identified	identify	VBN	I-VP	O	
,	,	,	O	O	
of	of	IN	B-PP	O	
whom	whom	WP	B-NP	O	
28	28	CD	B-NP	O	
died	die	VBD	B-VP	O	
within	within	IN	B-PP	O	
seven	seven	CD	B-NP	O	
days	day	NNS	I-NP	O	
and	and	CC	O	O	
were	be	VBD	B-VP	O	
excluded	exclude	VBN	I-VP	O	
from	from	IN	B-PP	O	
the	the	DT	B-NP	O	
analysis	analysis	NN	I-NP	O	
.	.	.	O	O	

All	All	DT	B-NP	O	
patients	patient	NNS	I-NP	O	
were	be	VBD	B-VP	O	
followed	follow	VBN	I-VP	O	
until	until	IN	B-PP	O	
discharge	discharge	NN	B-NP	O	
for	for	IN	B-PP	O	
both	both	DT	B-NP	O	
CNS	CNS	NN	I-NP	B-protein	
infections	infection	NNS	I-NP	O	
and	and	CC	O	O	
subsequent	subsequent	JJ	B-NP	O	
infectious	infectious	JJ	I-NP	O	
complications	complication	NNS	I-NP	O	
.	.	.	O	O	

Only	Only	RB	B-NP	O	
two	two	CD	I-NP	O	
patients	patient	NNS	I-NP	O	
,	,	,	O	O	
both	both	CC	O	O	
in	in	IN	B-PP	O	
the	the	DT	B-NP	O	
PRO	PRO	NN	I-NP	O	
group	group	NN	I-NP	O	
,	,	,	O	O	
developed	develop	VBD	B-VP	O	
CNS	CNS	NN	B-NP	O	
infection	infection	NN	I-NP	O	
.	.	.	O	O	

Both	Both	DT	B-NP	O	
infectious	infectious	JJ	I-NP	O	
complications	complication	NNS	I-NP	O	
(	(	(	O	O	
0.7	0.7	CD	B-NP	O	
vs	vs	IN	I-NP	O	
1.4	1.4	CD	B-NP	O	
per	per	IN	B-PP	O	
patient	patient	NN	B-NP	O	
;	;	:	O	O	
p	p	NN	B-NP	O	
<	<	SYM	B-NP	O	
0.05	0.05	CD	I-NP	O	
)	)	)	O	O	
and	and	CC	O	O	
infections	infection	NNS	B-NP	O	
secondary	secondary	JJ	B-ADJP	O	
to	to	TO	B-PP	O	
MDR	MDR	NN	B-NP	O	
pathogens	pathogen	NNS	I-NP	O	
(	(	(	O	O	
0.03	0.03	CD	B-NP	O	
vs	v	NNS	I-NP	O	
.	.	.	O	O	
0.33	0.33	CD	B-NP	O	
per	per	IN	B-PP	O	
patient	patient	NN	B-NP	O	
;	;	:	O	O	
p	p	NN	B-NP	O	
<	<	SYM	B-NP	O	
0.01	0.01	CD	I-NP	O	
)	)	)	O	O	
were	be	VBD	B-VP	O	
significantly	significantly	RB	B-ADJP	O	
more	more	RBR	I-ADJP	O	
common	common	JJ	I-ADJP	O	
in	in	IN	B-PP	O	
the	the	DT	B-NP	O	
PRO	PRO	NN	I-NP	O	
group	group	NN	I-NP	O	
.	.	.	O	O	

Twenty	Twenty	CD	B-NP	O	
-	-	HYPH	I-NP	O	
nine	nine	CD	I-NP	O	
percent	percent	NN	I-NP	O	
of	of	IN	B-PP	O	
the	the	DT	B-NP	O	
ventilator	ventilator	NN	I-NP	O	
-	-	HYPH	B-NP	O	
associated	associate	VBN	I-NP	O	
pneumonias	pneumonia	NNS	I-NP	O	
and	and	CC	O	O	
33%	33%	CD	B-NP	O	
of	of	IN	B-PP	O	
the	the	DT	B-NP	O	
blood	blood	NN	I-NP	O	
stream	stream	NN	I-NP	O	
infections	infection	NNS	I-NP	O	
in	in	IN	B-PP	O	
the	the	DT	B-NP	O	
PRO	PRO	NN	I-NP	O	
group	group	NN	I-NP	O	
were	be	VBD	B-VP	O	
MDR	MDR	NN	B-NP	B-protein	
,	,	,	O	O	
whereas	whereas	IN	O	O	
only	only	RB	B-NP	O	
two	two	CD	I-NP	O	
blood	blood	NN	I-NP	O	
stream	stream	NN	I-NP	O	
infections	infection	NNS	I-NP	O	
in	in	IN	B-PP	O	
the	the	DT	B-NP	O	
NONE	NONE	NN	I-NP	O	
group	group	NN	I-NP	O	
(	(	(	O	O	
4%	4%	CD	B-NP	O	
of	of	IN	B-PP	O	
the	the	DT	B-NP	O	
total	total	JJ	I-NP	O	
infections	infection	NNS	I-NP	O	
)	)	)	O	O	
were	be	VBD	B-VP	O	
MDR	MDR	NN	B-NP	B-protein	
.	.	.	O	O	

The	The	DT	B-NP	O	
routine	routine	JJ	I-NP	O	
use	use	NN	I-NP	O	
of	of	IN	B-PP	O	
prophylactic	prophylactic	JJ	B-NP	O	
antibiotics	antibiotic	NNS	I-NP	O	
for	for	IN	B-PP	O	
ICP	ICP	NN	B-NP	O	
monitor	monitor	NN	I-NP	O	
insertion	insertion	NN	I-NP	O	
is	be	VBZ	B-VP	O	
not	not	RB	I-VP	O	
warranted	warrant	VBN	I-VP	O	
.	.	.	O	O	

This	This	DT	B-NP	O	
practice	practice	NN	I-NP	O	
does	do	VBZ	B-VP	O	
not	not	RB	I-VP	O	
reduce	reduce	VB	I-VP	O	
the	the	DT	B-NP	O	
CNS	CNS	NN	I-NP	O	
infection	infection	NN	I-NP	O	
rate	rate	NN	I-NP	O	
and	and	CC	O	O	
is	be	VBZ	B-VP	O	
associated	associate	VBN	I-VP	O	
with	with	IN	B-PP	O	
more	more	JJR	B-NP	O	
MDR	MDR	NN	I-NP	O	
pathogens	pathogen	NNS	I-NP	O	
in	in	IN	B-PP	O	
any	any	DT	B-NP	O	
subsequent	subsequent	JJ	I-NP	O	
infectious	infectious	JJ	I-NP	O	
complications	complication	NNS	I-NP	O	
.	.	.	O	O	

